18th October 2022 – Online workshop to discuss Pharmacogenetics in Drug Discovery. Academics, clinicians, industry, regulators, patients, others, are invited to share their expertise in using pharmacogenomics (pgx) in drug discovery. Delegates will then have the opportunity to join groups to discuss the importance of pgx in the drug target, identification, and discovery pipeline. Click […]
*ISoP South Asian Chapter webinar “The Importance of Pharmacovigilance in South Asian Countries”
8 October 2022 from 16:00 – 18:00 hrs IST (Virtual). Please use the link below to register for the webinar free of charge here.
11th Biennial Conference on Signal Detection and Signal Management
29-30 June 2022, BMA House, London (UK) The main conference will take place on 29-30 June and is preceded by a pre-conference tutorial day on 28 June, which is open to all but is aimed at newcomers to signal detection. There is also the option to join remotely. For more information about the conference, including […]
UK Pharmacogenetics and Stratified Medicine Network 9th Annual Open Meeting 2022
15 June 2022, London (UK) The UK Pharmacogenetics & Stratified Medicine Network is pleased to announce details of our 9th Annual Open Meeting, which will take place on October 20, 2021 at the Royal College of Physicians, Regents Park, Central London. The meeting will be chaired by Professor Sir Munir Pirmohamed. #UKPGx2022 – For more […]
10th Bordeaux PharmacoEpi Festival
18-20 May 2022 (hybrid event) World-class experts will talk about the topic of their choice over 3 days from 1:30 p.m. to 5:45 p.m. (GMT +1) with live streaming of conference videos, or face-to-face at the University of Bordeaux (France). More information here.
*NASoP-DIA joint webinar series 2022
3 February, 3 March, 7 April, and 5 May, 2022 (11.00 EST). DIA and NASoP have collaborated to offer a series of four, one-hour, monthly webinars on the topic of Drug Interactions, led by renowned experts, in February to May 2022. Registration is free. The webinars are intended to encourage discussion within the drug safety […]
